Stratec SE (XETRA:SBS) — Market Cap & Net Worth
Market Cap & Net Worth: Stratec SE (SBS)
Stratec SE (XETRA:SBS) has a market capitalization of $267.43 Million (€228.75 Million) as of September 19, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #15464 globally and #1500 in its home market, demonstrating a -2.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Stratec SE's stock price €24.05 by its total outstanding shares 12155942 (12.16 Million). Also see Stratec SE (SBS) total assets for a full breakdown of the balance sheet.
Stratec SE Market Cap History: 2015 to 2026
Stratec SE's market capitalization history from 2015 to 2026. Data shows change from $777.72 Million to $341.79 Million (-5.41% CAGR). Also see Stratec SE cash conversion from operations for how efficiently the company converts equity into cash flow.
Stratec SE Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Stratec SE's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check SBS stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.27x
Stratec SE's market cap is 1.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $592.48 Million | $184.91 Million | $19.57 Million | 3.20x | 30.27x |
| 2017 | $849.65 Million | $209.76 Million | $25.64 Million | 4.05x | 33.14x |
| 2018 | $666.82 Million | $187.82 Million | $8.97 Million | 3.55x | 74.35x |
| 2019 | $819.51 Million | $221.64 Million | $14.44 Million | 3.70x | 56.75x |
| 2020 | $1.67 Billion | $250.10 Million | $25.18 Million | 6.67x | 66.23x |
| 2021 | $1.89 Billion | $287.33 Million | $39.96 Million | 6.56x | 47.19x |
| 2022 | $1.12 Billion | $274.62 Million | $29.22 Million | 4.08x | 38.34x |
| 2023 | $639.12 Million | $270.41 Million | $15.37 Million | 2.36x | 41.58x |
| 2024 | $423.50 Million | $257.62 Million | $16.02 Million | 1.64x | 26.43x |
| 2025 | $319.05 Million | $250.86 Million | -$242.00K | 1.27x | N/A |
Competitor Companies of SBS by Market Capitalization
Companies near Stratec SE in the global market cap rankings as of September 19, 2026. Review Stratec SE tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Stratec SE by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Stratec SE Historical Marketcap From 2015 to 2026
Between 2015 and today, Stratec SE's market cap moved from $777.72 Million to $ 341.79 Million, with a yearly change of -5.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €341.79 Million | +7.13% |
| 2025 | €319.05 Million | -24.66% |
| 2024 | €423.50 Million | -33.74% |
| 2023 | €639.12 Million | -42.95% |
| 2022 | €1.12 Billion | -40.59% |
| 2021 | €1.89 Billion | +13.09% |
| 2020 | €1.67 Billion | +103.46% |
| 2019 | €819.51 Million | +22.90% |
| 2018 | €666.82 Million | -21.52% |
| 2017 | €849.65 Million | +43.41% |
| 2016 | €592.48 Million | -23.82% |
| 2015 | €777.72 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Stratec SE was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $267.43 Million USD |
| MoneyControl | $267.43 Million USD |
| MarketWatch | $267.43 Million USD |
| marketcap.company | $267.43 Million USD |
| Reuters | $267.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and softwar… Read more